News and Events
Cell Bridge Strategies Names New Chief Financial Officer
BOERNE, Texas — Life science, regenerative medicine, and cell therapy business consulting firm Cell Bridge Strategies recently announced its latest senior-level executive to join their growing team. Neil Kellen, Principal Consultant and Chief Financial Officer, comes to Cell Bridge Strategy after more than thirty years of experience in the financial services industry.
Cell Bridge Strategies is a global growth consulting firm that seeks to assist both executives and investors in the life sciences, regenerative medicine, cell, and cell-gene therapy industries make informed and effective business decisions. The organization leverages its integrated expertise in cell therapy science, business modeling, regulatory compliance, data and technology infrastructure, and biotech manufacturing to help life science companies chart their growth plans in a manner that ensures each company’s alignment with the market. Its team is comprised of expert analysts, scientists, and life science executives who all possess a firm understanding of both the scientific and operational aspects of the business in order to develop a holistic approach to strategic planning for unbridled business growth.
Since 2003, Kellen has held C-Level roles for a range of organizations, utilizing his leadership presence and strategic thinking to develop market analyses that were instrumental in executive decision-making. “I look forward to continue leveraging the skills I have carefully honed over the years to help our clients develop a full understanding of their potential market and business growth opportunities in order to make confident and informed decisions for their organization,” explains Mr. Kellen.
Jane Andrews, Cell Bridge Strategies’ founder and CEO, shared, “Having Mr. Kellen join our growing team is an exciting step for Cell Bridge Strategies as he has many years of experience in building systems to improve integration between operations and finance. His dedicated expertise lends itself to our strategic offerings, such as our Top Down— Bottom Up™ services.”
Cell Bridge Strategies’ Top Down — Bottom Up™ solution addresses key questions to determining what will be successful in the given marketplace by evaluating external and internal forces to build a unique framework for financial and strategic plans. These plans help growing life science companies to attract partners and investors.
About Cell Bridge Strategies, LLC
Cell Bridge Strategies, LLC is an international growth consulting firm that helps cell & gene therapy companies bridge the path between science and business. Our team of experts, each with 20+ years of industry knowledge, guide executives through the challenges of strategy, production, technology, funding milestones and regulatory hurdles. We help companies advance their products and increase valuation while building their revenue streams. By providing the right tools and solutions we ensure companies match their core assets to optimal growth opportunities. Let us help you to succeed faster, with lower risk, and greater returns on investment. For more information, visit cellbridgestrategies.com.